AKT1 and posterior cortical atrophy: The phosphoinositide 3-kinase (PI3K)/AKT signaling pathway, which is aberrantly activated in approximately 60% of PCa patients [7], is associated with adverse clinicopathological variables and decreased disease-specific survival [8].